Ventricular remodeling

Critical Care Nursing Clinics of North America

Volumn 15, Issue 4, 2003, Pages 407-411

  Paul, Sara ^a,b  

^a Hickory Cardiology Associates   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CYTOKINE; ENDOTHELIN 1; NEUROHORMONE; NORADRENALIN; VASOPRESSIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CYTOKINE RELEASE; DISEASE COURSE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW; VASCULAR PATENCY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART LEFT VENTRICLE HYPERTROPHY; PHYSIOLOGY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SYSTOLE; TIME;

CYTOKINES; DIABETES COMPLICATIONS; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIAL INFARCTION; NEUROTRANSMITTER AGENTS; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SYSTOLE; TIME FACTORS; VENTRICULAR REMODELING;

EID: 1442358887     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00089-8     Document Type: Review

References (32)

1. Vasam R., Larson M., Benjamin E., et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 336:1997;1350-1355
2. Thomas K., Redfield M. Asymptomatic left ventricular dysfunction. Heart Fail Rev. 2:1997;11-22
3. Kannel W., Belanger A. Epidemiology of heart failure. Am Heart J. 121:1991;951-957
4. Smith W. Epidemiology of congestive heart failure. Am J Cardiol. 55:1985;3A-8A
5. Sutton M.S.J., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 101:2000;2981-2988
6. Giannuzzi P., Temporelli P., Bosimini E., et al. Heterogeneity of left ventricular remodeling after acute myocardial infarction. Am Heart J. 141:2001;131
7. Korup E., Dalsgaard D., Nyvad O., et al. Comparisons of degrees of left ventricular dilation within 3 hours and up to 6 days after onset of first acute myocardial infarction. Am J Cardiol. 80:1997;449
8. Erlebacher J., Weiss J., Weisfeldt M., et al. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol. 4:1984;201-208
9. Cleutjens J., Kandala J., Guarda E., et al. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 27:1995;1281-1292
10. Spinale F., Coker M., Thomas C., et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Circ Res. 82:1998;482-495
11. Dollery C., McEwan J., Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868
12. Sadoshima J., Jahn L., Takahashi T., et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: an in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 267:1992;10551-10560
13. Lew W., Chen Z., Guth B., et al. Mechanisms of augmented segment shortening in nonischemic areas during acute ischemia of the canine left ventricle. Circ Res. 56:1985;351-358
14. Anversa P., Olivetti G., Capasso J. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol. 68:1991;7D-16D
15. Francis G., McDonald K. Left ventricular hypertrophy: an initial response to myocardial injury. Am J Cardiol. 69:1992;3G-6G
16. Lindpaintner K., Lu W., Neidermajer N., et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 25:1993;133-143
17. Cohn J., Ferrari R., Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 35:2000;569-582
18. Schneider M., Roberts R., Parker T. Modulation of cardiac genes by mechanical stress: the oncogene signaling hypothesis. Mol Biol Med. 8:1991;167-183
19. Komuro I., Kaida T., Shibazake Y., et al. Stretching cardiac myocytes stimulates proto-oncogene expression. J Biol Chem. 265:1990;3595-3598
20. Francis G. Pathophysiology of chronic heart failure. Am J Med. 110:2001;37S-46S
21. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 378:1997;151-160
22. Brilla C., Zhou G., Matsubara L., et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Immunol. 26:1994;809-820
23. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1206
24. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236
25. Cohen M., Yang X., Neumann T., et al. Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts. Circulation. 102:2000;579
26. Mitchell G., Lamas G., Vaughan D., et al. Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol. 19:1992;1136
27. Jeremy R., Hackworthy R., Bautovich G., et al. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 9:1987;989-995
28. Pirolo J., Hutchins G., Moore G. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol. 7:1986;349-354
29. Massie B., Fisher S., Deedwania P., et al. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure (CHF-STAT Investigation). Circulation. 93:1996;2128-2134
30. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533
31. Packer M., Carver J., Rodeheffer R., et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475
32. Packer M. Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur Heart J. 16:(Suppl F):1995;4-6